Stereotaxis (STXS) News
Filter STXS News Items
STXS News Results
|Loading, please wait...|
STXS News Highlights
- For STXS, its 30 day story count is now at 5.
- Over the past 18 days, the trend for STXS's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about STXS are ST and KE.
Latest STXS News From Around the Web
Below are the latest news stories about Stereotaxis Inc that investors may wish to consider to help them evaluate STXS as an investment opportunity.
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, chairman and CEO, will present at three investor conferences in the first quarter 2022.
ST. LOUIS, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2021 fourth quarter and full year ended December 31, 2021 on Thursday, March 3, 2022 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments
Investment company Roubaix Capital, LLC (Current Portfolio) buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Xometry Inc, First Citizens BancShares Inc, sells Rogers Corp, Alliance Data Systems Corp, Hayward Holdings Inc, Gates Industrial Corp PLC, Aspen Aerogels Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Roubaix Capital, LLC.
Fuwai Central China Cardiovascular Hospital Becomes First to Offer Advanced Robotic Treatment for Heart Rhythm Disorders in Central China
ST. LOUIS, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Fuwai Central China Cardiovascular Hospital has become the first in central China to establish a robotic electrophysiology program with installation of Stereotaxis’ Robotic Magnetic Navigation technology. Chief physicians for arrhythmia treatment, Dr. Chen Ke and Dr. Song Weifeng, successfully performed their first ro
HonorHealth Scottsdale Shea Medical Center Builds Advanced Robotic Program to Treat Heart Rhythm Disorders
ST. LOUIS, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that HonorHealth has established a robotic electrophysiology program as part of its Cardiovascular Center of Excellence at HonorHealth Scottsdale Shea Medical Center in Scottsdale, Arizona. HonorHealth is among the first in the nation to offer the Genesis Robotic Magnetic Navigation (RMN) system to patients receiving minim
Morgan Stanley boosted its holdings in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 3,094.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 315,717 shares of the companys stock after acquiring an additional 305,835 shares during the quarter. Morgan Stanleys holdings in Stereotaxis were 
No summary available.
Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication
ST. LOUIS, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS ), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a publication in Frontiers in Cardiovascular Medicine titled "Atrial Fibrillation Ablation Using Robotic Magnetic Navigation Reduces the Incidence of Silent Cerebral Embolism." This multi-center, prospective study evaluated 166 patients with paroxysmal or persistent Atrial Fibrillation (AF) who underwent pulmonary vein isolation using either Stereotaxis'' Robotic Magnetic Navigation (RMN) technology or manual contact force ablation catheters. All patients received cerebral magnetic resonance imaging within 48 hours before and after the ablation procedure to assess cerebral embolism. Patients treated using R...
AI-based Surgical Robots: Market Integration of Latest Technologies into Existent Offerings with Key Players | TransEnterix, Mazor Robotics, Stereotaxis, Medrobotics Corp
Qurates most recent research report on AI-based Surgical Robots was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on AI-based Surgical Robots is extensive and consist of
Zacks Investment Research cut shares of Stereotaxis (NYSEAMERICAN:STXS) from a hold rating to a strong sell rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospitals interventional surgical suite to enhance the treatment of coronary artery